{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:26:14Z","timestamp":1791192374278,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s11605-008-0646-0","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T12:03:57Z","timestamp":1218715437000},"page":"1738-1744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":212,"title":["Use of Infliximab within 3\u00a0Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn\u2019s Patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Kweku A.","family":"Appau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor W.","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret","family":"Lashner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feza","family":"Remzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Brzezinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi P.","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1007\/s11605-008-0646-0_bb0010","first-page":"55","article-title":"Medical management of patients with difficult-to-treat inflammatory bowel disease","volume":"45","author":"van Hogezand","year":"1994","journal-title":"Neth J Med."},{"issue":"11","key":"10.1007\/s11605-008-0646-0_bb0015","first-page":"245","article-title":"Conservative therapy of ulcerative colitis and Crohn disease","volume":"109","author":"Rasenack","year":"1991","journal-title":"Fortschr Med."},{"issue":"4","key":"10.1007\/s11605-008-0646-0_bb0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00001574-199907000-00006","article-title":"Medical therapy for Crohn\u2019s disease","volume":"15","author":"Hanauer","year":"1999","journal-title":"Curr Opin Gastroenterol."},{"issue":"Suppl 2","key":"10.1007\/s11605-008-0646-0_bb0025","first-page":"S17","article-title":"Clinical perspectives in Crohn\u2019s disease. Turning traditional treatment strategies on their heads: current evidence for \u201cstep-up\u201d versus \u201ctop-down\u201d","volume":"7","author":"Hanauer","year":"2007","journal-title":"Rev Gastroenterol Disord."},{"issue":"4","key":"10.1007\/s11605-008-0646-0_bb0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MOG.0b013e32815b601b","article-title":"Biological therapies in inflammatory bowel disease: top-down or bottom-up?","volume":"23","author":"Oldenburg","year":"2007","journal-title":"Curr Opin Gastroenterol."},{"issue":"5","key":"10.1007\/s11605-008-0646-0_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02561704","article-title":"The resectional reoperation rate for Crohn\u2019s disease in a general community hospital","volume":"26","author":"Frikker","year":"1983","journal-title":"Dis Colon Rectum."},{"issue":"9","key":"10.1007\/s11605-008-0646-0_bb0040","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/bjs.5050","article-title":"Recurrence after segmental resection for colonic Crohn\u2019s disease","volume":"92","author":"Polle","year":"2005","journal-title":"Br J Surg."},{"issue":"1","key":"10.1007\/s11605-008-0646-0_bb0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/23771003.1996.12314816","article-title":"Maintenance strategies in Crohn\u2019s disease","volume":"31","author":"Sachar","year":"1996","journal-title":"Hospital Practice (1995)"},{"issue":"1","key":"10.1007\/s11605-008-0646-0_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9610(84)90035-7","article-title":"Surgical management of Crohn\u2019s disease involving the duodenum","volume":"147","author":"Murray","year":"1984","journal-title":"Am J Surg."},{"issue":"15","key":"10.1007\/s11605-008-0646-0_bb0055","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1007\/s11605-008-0646-0_bb0060","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00054725-199811000-00014","article-title":"Infliximab approved for use in Crohn\u2019s disease: a report on the FDA GI Advisory Committee conference","volume":"4","author":"Kornbluth","year":"1998","journal-title":"Inflamm Bowel Dis."},{"issue":"9317","key":"10.1007\/s11605-008-0646-0_bb0065","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet."},{"issue":"10","key":"10.1007\/s11605-008-0646-0_bb0070","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/j.1572-0241.2003.07674.x","article-title":"The effects of infliximab maintenance therapy on health-related quality of life","volume":"98","author":"Feagan","year":"2003","journal-title":"Am J Gastroenterol."},{"issue":"8","key":"10.1007\/s11605-008-0646-0_bb0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00063-003-1282-9","article-title":"Suspected cases of severe side effects after infliximab (Remicade) in Germany","volume":"98","author":"Andus","year":"2003","journal-title":"Med Klin (Munich)."},{"issue":"6","key":"10.1007\/s11605-008-0646-0_bb0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cgh.2007.02.016","article-title":"Serious adverse events with infliximab: analysis of spontaneously reported adverse events","volume":"5","author":"Hansen","year":"2007","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"10.1007\/s11605-008-0646-0_bb0085","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10350-006-0847-0","article-title":"Patient preferences between surgical and medical treatment in Crohn\u2019s disease","volume":"50","author":"Byrne","year":"2007","journal-title":"Dis Colon Rectum."},{"issue":"12","key":"10.1007\/s11605-008-0646-0_bb0090","first-page":"1035","article-title":"Clinical use of anti-TNF-alpha biological agents-a guide for GPs","volume":"36","author":"Chang","year":"2007","journal-title":"Aust Fam Physician."},{"issue":"5","key":"10.1007\/s11605-008-0646-0_bb0095","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jamcollsurg.2006.12.044","article-title":"Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis","volume":"204","author":"Selvasekar","year":"2007","journal-title":"J Am Coll Surg."},{"issue":"8","key":"10.1007\/s11605-008-0646-0_bb0100","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10350-008-9364-7","article-title":"Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy","volume":"51","author":"Mor","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1007\/s11605-008-0646-0_bb0105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1572-0241.2004.04148.x","article-title":"Early postoperative complications are not increased in patients with Crohn\u2019s disease treated perioperatively with infliximab or immunosuppressive therapy","volume":"99","author":"Colombel","year":"2004","journal-title":"Am J Gastroenterol."},{"issue":"7","key":"10.1007\/s11605-008-0646-0_bb0110","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2004.01904.x","article-title":"The risk of post-operative complications associated with infliximab therapy for Crohn\u2019s disease: a controlled cohort study","volume":"19","author":"Marchal","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"issue":"4","key":"10.1007\/s11605-008-0646-0_bb0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2036.2001.00956.x","article-title":"Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn\u2019s disease","volume":"15","author":"Cornillie","year":"2001","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"10.1007\/s11605-008-0646-0_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14740338.5.1.9","article-title":"Toxicity of infliximab in the course of treatment of Crohn\u2019s disease","volume":"5","author":"Bratcher","year":"2006","journal-title":"Expert Opin Drug Saf."},{"issue":"4","key":"10.1007\/s11605-008-0646-0_bb0125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.gtc.2006.09.008","article-title":"Safety of infliximab and other biologic agents in the inflammatory bowel diseases","volume":"35","author":"Reddy","year":"2006","journal-title":"Gastroenterol Clin North Am."},{"issue":"4","key":"10.1007\/s11605-008-0646-0_bb0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/archsurg.143.4.406","article-title":"Comparison of outcomes after restorative proctocolectomy with or without defunctioning ileostomy","volume":"143","author":"Weston-Petrides","year":"2008","journal-title":"Arch Surg."},{"issue":"6","key":"10.1007\/s11605-008-0646-0_bb0135","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.semarthrit.2004.11.006","article-title":"The benefit\/risk profile of TNF-blocking agents: findings of a consensus panel","volume":"34","author":"Hochberg","year":"2005","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"10.1007\/s11605-008-0646-0_bb0140","first-page":"135","article-title":"The nonreflux determinant of esophagitis","volume":"63","author":"Kalkay","year":"1975","journal-title":"Am J Gastroenterol."},{"issue":"12","key":"10.1007\/s11605-008-0646-0_bb0145","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.4049\/jimmunol.159.12.6276","article-title":"A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn\u2019s disease","volume":"159","author":"Plevy","year":"1997","journal-title":"J Immunol."}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-008-0646-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11605-008-0646-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23073894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23073894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-008-0646-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:29:18Z","timestamp":1761074958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23073894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1091255X23073894"],"URL":"https:\/\/doi.org\/10.1007\/s11605-008-0646-0","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Infliximab within 3\u00a0Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn\u2019s Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-008-0646-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}